Ribosome-Engineered


Journal

Applied and environmental microbiology
ISSN: 1098-5336
Titre abrégé: Appl Environ Microbiol
Pays: United States
ID NLM: 7605801

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 18 06 2020
accepted: 03 08 2020
pubmed: 18 8 2020
medline: 15 12 2020
entrez: 18 8 2020
Statut: epublish

Résumé

Differences in individual host responses have emerged as an issue regarding the health benefits of probiotics. Here, we applied ribosome engineering (RE) technology, developed in an actinomycete study, to

Identifiants

pubmed: 32801170
pii: AEM.01448-20
doi: 10.1128/AEM.01448-20
pmc: PMC7531950
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Mucins 0
Glyceraldehyde-3-Phosphate Dehydrogenases EC 1.2.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Ishida et al.

Références

Antonie Van Leeuwenhoek. 1997 Feb;71(1-2):117-28
pubmed: 9049023
Res Microbiol. 2008 Nov-Dec;159(9-10):685-91
pubmed: 18790050
J Cell Physiol. 2019 Jun;234(6):8008-8018
pubmed: 30317594
Biosci Biotechnol Biochem. 2004 May;68(5):1004-10
pubmed: 15170102
J Appl Microbiol. 2008 Jun;104(6):1667-74
pubmed: 18194256
J Microbiol Biotechnol. 2009 Dec;19(12):1635-43
pubmed: 20075631
Allergy. 2002 Mar;57(3):243-6
pubmed: 11906339
Br J Dermatol. 2006 Dec;155(6):1256-61
pubmed: 17107398
Mucosal Immunol. 2018 Sep;11(5):1316-1328
pubmed: 29875401
Cell. 2018 Sep 6;174(6):1388-1405.e21
pubmed: 30193112
Lancet. 2001 Apr 7;357(9262):1076-9
pubmed: 11297958
Microbiology (Reading). 2003 Nov;149(Pt 11):3299-3309
pubmed: 14600242
Oral Microbiol Immunol. 2009 Jun;24(3):224-30
pubmed: 19416452
Antimicrob Agents Chemother. 1998 Aug;42(8):2041-7
pubmed: 9687404
Int J Syst Evol Microbiol. 2020 Apr;70(4):2782-2858
pubmed: 32293557
Biotechnol Lett. 2010 Apr;32(4):517-20
pubmed: 20033833
Lett Appl Microbiol. 2009 May;48(5):618-22
pubmed: 19416463
J Biol Chem. 2007 Aug 3;282(31):22651-61
pubmed: 17553795
Biochim Biophys Acta. 1999 Jul 13;1432(2):222-33
pubmed: 10407144
Front Microbiol. 2019 Mar 14;10:477
pubmed: 30923519
Appl Microbiol Biotechnol. 2013 Jan;97(1):87-98
pubmed: 23143535
Curr Obes Rep. 2020 Sep;9(3):179-192
pubmed: 32472285
Cell Physiol Biochem. 2019;52(3):517-531
pubmed: 30897319
Appl Environ Microbiol. 2016 Jan 04;82(6):1722-1733
pubmed: 26729723
PLoS One. 2014 Mar 14;9(3):e90643
pubmed: 24632842
Mol Genet Genomics. 2004 Apr;271(3):317-24
pubmed: 14966659
Appl Environ Microbiol. 2006 Jan;72(1):71-7
pubmed: 16391027
Biochim Biophys Acta. 1999 Jul 13;1432(2):159-84
pubmed: 10407139
Anim Sci J. 2013 Feb;84(2):150-8
pubmed: 23384357
Food Res Int. 2017 Apr;94:45-53
pubmed: 28290366
Probiotics Antimicrob Proteins. 2012 Dec;4(4):217-26
pubmed: 26782181

Auteurs

Minori Ishida (M)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Fu Namai (F)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Suguru Shigemori (S)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Shoko Kajikawa (S)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Masami Tsukagoshi (M)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Takashi Sato (T)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Tasuku Ogita (T)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan.

Takeshi Shimosato (T)

Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Kamiina, Nagano, Japan shimot@shinshu-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH